A Randomised Controlled Trial Of Non-invasive Ventilation In Stable, Hypercapnic Chronic Airflow Limitation
Funder
National Health and Medical Research Council
Funding Amount
$331,622.00
Summary
Chronic airflow limitation is a major cause of illness and death in Australia. Long term oxygen therapy is well established as one means of assisting people with chronic lung disease. Survival is still poor particularly when an individual is hypercapnic. Non-invasive ventilation used at night with a mask has been used in chronic hypercapnic respiratory failure from other causes with very good results. This study looks at whether non-invasive mask ventilation improves survival, improves clinical ....Chronic airflow limitation is a major cause of illness and death in Australia. Long term oxygen therapy is well established as one means of assisting people with chronic lung disease. Survival is still poor particularly when an individual is hypercapnic. Non-invasive ventilation used at night with a mask has been used in chronic hypercapnic respiratory failure from other causes with very good results. This study looks at whether non-invasive mask ventilation improves survival, improves clinical outcome measures and reduces health costs in people with chronic airflow limitation. The ventilatory support will be used at night during sleep and will be a bilevel positive airway pressure device. Apart from measuring the cost-benefit of home ventilatory support, this study will examine the relationship between the time of commencement of home ventilatory support and outcomes. In addition the relationships between daytime awake PaCO2, lung function, and body mass in CAL patients and the likely response to home ventilatory support will be examined.Read moreRead less
Improving Long-term Mortality Rates Following Sepsis.
Funder
National Health and Medical Research Council
Funding Amount
$99,682.00
Summary
It is estimated that 37.9 million patients survive sepsis each year. Studies have demonstrated that among patients who survive for 30 days after admission for sepsis, over 40% die in the following two years. There are currently no guidelines that provide recommendations on post-hospital management of sepsis. This research programme aims to identify those patients at greatest risk of death and implement post-sepsis care with the aim to significantly reduce long-term mortality after sepsis.
Longitudinal Communication Outcomes Following Traumatic Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$798,171.00
Summary
Traumatic brain injury (TBI) is the leading cause of disability in young Australians. The condition frequently manifests in impaired verbal communication. Communication is essential to successful rehabilitation, and return to society. However, the critical time for delivery of optimal treatment for communication remains unknown. This prospective longitudinal study will examine communication recovery following (TBI) to identify predictors of recovery and the best time to offer treatment.
Reversing Oxidative Inhibition Of The Na-K Pump By Beta3 Adrenergic Agonists: Implications For Heart Failure Therapy
Funder
National Health and Medical Research Council
Funding Amount
$533,541.00
Summary
Heart failure is a debilitating condition characterised by a decreased heart pump function. Raised Na+ levels and increased oxidative stress in cardiac cells are important in its causation. While traditional antioxidants are not useful in treatment, we have found that a group of drugs designed to induce weight loss can reverse oxidative inhibition of the mechanism that pumps Na+ out of heart cells. The effect of these drugs on the Na+ pumping mechanism and heart failure will be examined.
Early Antipsychotic Exposure During Childhood And Adolescence: Does It Lead To Long Term Brain And Behaviour Changes In Adulthood?
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Mental health problems affect at least 9% of Australia's 4.1 million children. With the trend towards prescribing antipsychotic medication “off-label” to control these mental disorders in young people and the long-term consequences of doing so unknown, this timely research program aims to address a critical health issue by providing clinicians with valuable information so they can better balance the risk/benefit ratio before prescribing antipsychotics to young people.
Evaluating “Standing Tall” – An Engaging Home-based Exercise Program Using Mobile Technology For Maximizing Long-term Adherence And Preventing Falls In Older People: Randomized Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$791,081.00
Summary
Current evidence suggests that older people have to exercise for two hours per week for six months to prevent falls, with a strong focus on balance exercises. We have developed and tested an engaging home-based balance training program delivered through mobile (tablet) technology, called ‘Standing Tall’. We propose a randomised controlled trial to examine the effectiveness of our program for preventing falls in 500 community-dwelling older people, in addition to adherence- and cost-analyses.
Implementing Multiple Imputation With Sensitivity Analysis In Large-scale Longitudinal Studies
Funder
National Health and Medical Research Council
Funding Amount
$473,507.00
Summary
Missing data arise in most research studies and if not handled appropriately can mean the study results are not correct. With researchers now conducting larger and longer studies the challenges posed by missing data are increasing. In this grant we study a powerful technique for handling missing data, which in its current form often cannot be applied effectively in large studies. By developing this approach we will improve the accuracy of results from large-scale epidemiological studies.
Extended Follow Up Of The RENAL Study And Individual Patient Data Meta-analysis In Acute Kidney Injury
Funder
National Health and Medical Research Council
Funding Amount
$650,271.00
Summary
Acute kidney failure is increasingly common and associated with very high mortality. The long term consequences for patients and their kidney function are unknown. By extending follow up of the RENAL study, which explored how the dose of dialysis affected survival, and combining it with other trials from around the world, we will provide the strongest evidence regarding how dialysis treatment can reduce this mortality and define the long term consequences of this condition.